Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023890 (
cirrhosis
)
42,195
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Intracellular protein molecules are detected in the blood following release from damaged cells.
PDCD5
is widely expressed in most types of normal human tissue and is unregulated in cells undergoing apoptosis. It is therefore hypothesized that release of
PDCD5
into the circulation might be a specific marker of apoptosis. In this study, a sandwich ELISA was developed for quantification of soluble
PDCD5
protein and used to investigate serum
PDCD5
levels in liver diseases. The highest levels of
PDCD5
were detected in acute icteric hepatitis (AIH) patients compared with normal subjects and other detected liver diseases, such as chronic active hepatitis B (CAHB), chronic persistent hepatitis B (CPHB) and and
liver cirrhosis
(LC). Increased
PDCD5
levels correlated well with ALT and AST in AIH and CAHB patients. In patients with CPHB, increased
PDCD5
levels correlated well with AST, TBI, DBIL, and IBIL. In LC patients,
PDCD5
levels correlated well with AST/ALT and DBIL. More importantly, increased
PDCD5
levels were also observed in patients with normal ALT or AST levels. These data demonstrate a correlation between increased levels of
PDCD5
in serum and liver disease progression and indicate the potential utility of serum
PDCD5
as a biomarker for monitoring liver injury.
...
PMID:Serum programmed cell death protein 5 (PDCD5) levels is upregulated in liver diseases. 2365 49